Revenue: The sum of all revenue fields included for a company's operating activities.
Acumen Pharmaceuticals, Inc. (ABOS) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-40.95M |
|
-- |
|
-- |
|
$41.75M |
|
$-41.75M |
|
$0.80M |
|
$-40.95M |
|
$-40.95M |
|
$-40.95M |
|
$-40.95M |
|
$-40.95M |
|
$-40.95M |
|
$-41.75M |
|
$-41.76M |
|
60.57M |
|
60.57M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$148.40M |
|
-- |
|
$23.49M |
|
$171.90M |
|
$24.86M |
|
$29.88M |
|
$29.96M |
|
$54.82M |
|
$117.08M |
|
$117.08M |
|
$117.08M |
|
60.57M |
|
| Cash Flow Statement Financials | |
$-65.95M |
|
$67.17M |
|
$-0.04M |
|
$35.86M |
|
$37.04M |
|
$1.18M |
|
$4.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.97 |
|
-- |
|
-- |
|
0.20 |
|
0.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-66.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.98% |
|
-34.98% |
|
-23.82% |
|
-27.86% |
|
$1.93 |
|
$-1.09 |
|
$-1.09 |
|